Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pentosan polysulfate
Drug ID BADD_D01728
Description Pentosan polysulfate is a sulfated pentosyl polysaccharide with heparin-like properties.
Indications and Usage For the relief of bladder pain or discomfort associated with interstitial cystitis.
Marketing Status Prescription
ATC Code C05BA04; G04BX15
DrugBank ID DB00686
KEGG ID D05428
MeSH ID D010426
PubChem ID 37720
TTD Drug ID D0F8CM
NDC Product Code Not Available
Synonyms Pentosan Sulfuric Polyester | Polyester, Pentosan Sulfuric | Sulfuric Polyester, Pentosan | Pentosane Sulfuric Polyester | Polyester, Pentosane Sulfuric | Sulfuric Polyester, Pentosane | Xylan Sulfate | Sulfate, Xylan | Polypentose Sulfate | Sulfate, Polypentose | Polysulfated Xylan | Xylan, Polysulfated | Fibrocid | Hemoclar | HOE-BAY-946 | HOE BAY 946 | HOE-BAY 946 | BAY-946 | BAY 946 | HOE-946 | HOE 946 | Xylan SP54 | SP54, Xylan | Pentosan Polysulphate Sodium | Polysulphate Sodium, Pentosan | Sodium, Pentosan Polysulphate | Pentosan Polysulfate Sodium | Polysulfate Sodium, Pentosan | Sodium, Pentosan Polysulfate | PZ-68 | PZ 68 | PZ68 | SP-54 | SP 54 | SP54 | Tavan SP 54 | SP 54, Tavan | Elmiron | Pentosan Polysulfate | Polysulfate, Pentosan
Chemical Information
Molecular Formula C10H18O21S4
CAS Registry Number 37300-21-3
SMILES C1C(C(C(C(O1)OC2COC(C(C2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.0020.000857%
Agitation19.06.02.001; 17.02.05.012--
Alopecia23.02.02.0010.003427%
Amblyopia06.02.01.001--Not Available
Amenorrhoea05.05.01.002; 21.01.02.001--
Anaemia01.03.02.001--
Angina pectoris24.04.04.002; 02.02.02.002--
Arthralgia15.01.02.001--
Chronic myeloid leukaemia16.01.07.001; 01.10.07.001--Not Available
Colitis07.08.01.0010.000857%
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Cystitis interstitial20.03.02.005; 10.02.01.0390.001142%Not Available
Dehydration14.05.05.0010.000571%
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Drug hypersensitivity10.01.01.0010.000857%Not Available
Dyspepsia07.01.02.001--
Dysphagia07.01.06.0030.001142%
Dyspnoea02.01.03.002; 22.02.01.004--
Ecchymosis23.06.01.001; 01.01.03.001; 24.07.06.002--Not Available
Epistaxis24.07.01.005; 22.04.03.001--
Feeling abnormal08.01.09.0140.000571%Not Available
Flatulence07.01.04.002--
Gastritis07.08.02.001--
Gastrointestinal pain07.01.05.005--
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages